SCHEMBL30550477

SCHEMBL30550477

COc1cc(Br)c2c(c1)CN(Cc1ccccc1)C2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.54
TMEM97 Q5BJF2 3/20 0.54
DRD4 P21917 3/20 0.54
HTR1A P08908 2/20 0.54
HTR2C P28335 2/20 0.54
HTR2B P41595 2/20 0.54
SLC6A3 Q01959 2/20 0.54
ADRA2A P08913 1/20 0.54
ADRA2B P18089 1/20 0.54
ADRA2C P18825 1/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A4 P31645 1/20 0.54
OPRK1 P41145 1/20 0.54
HTR5A P47898 1/20 0.54
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31014028 0.90 ABCB1 (0.49) SIGMAR1TMEM97DRD4HTR1AHTR2C
SCHEMBL25592789 0.80 SIGMAR1 (0.41) SIGMAR1TMEM97DRD4HTR1AHTR2C
SCHEMBL19358129 0.80 KDM4E (0.46) ALDH1A1MAPTLMNAKDM4EKMT2A
SCHEMBL3693352 0.80 SIGMAR1 (0.75) SIGMAR1TMEM97DRD4HTR1AHTR2C
SCHEMBL16593588 0.78 PTGER4 (0.57) SIGMAR1TMEM97DRD4HTR1AHTR2C
SCHEMBL18356020 0.78 SIGMAR1 (0.51) SIGMAR1TMEM97DRD4HTR1AHTR2C
SCHEMBL19357796 0.77 HDAC1 (0.44) ALDH1A1MAPTLMNAKDM4EMAPK1
SCHEMBL629986 0.76 SIGMAR1 (0.46) SIGMAR1TMEM97DRD4HTR1AHTR2C
SCHEMBL30550496 0.75 ALDH1A1 (0.32) ALDH1A1
SCHEMBL5449836 0.75 HTR1A (0.54) SIGMAR1TMEM97DRD4HTR1AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514771-A Carboxylic acid compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-08-01 CN disclosed